Showing results (781-790 of 1,211) with videos related to

Sort By:
Pageof 122
Circulation. Heart Failure|October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.
European Journal of Heart Failure|January 6, 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failureFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
European Journal of Heart Failure|September 2, 2022
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trialOtavio Berwanger, Marc Pfeffer, Brian Claggett, et al.
JAMA Cardiology|February 17, 2021
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection FractionDavid D Berg, Pardeep S Jhund, Kieran F Docherty, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 24, 2022
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trialsAjay K Singh, Finnian R McCausland, Brian L Claggett, et al.
Circulation|August 27, 2020
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection FractionFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
European Journal of Heart Failure|March 2, 2006
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunctionLars Køber, Karl Swedberg, John J V McMurray, et al.
The New England Journal of Medicine|December 3, 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A Pfeffer, Brian Claggett, Rafael Diaz, et al.
The New England Journal of Medicine|September 17, 2010
Erythropoietic response and outcomes in kidney disease and type 2 diabetesScott D Solomon, Hajime Uno, Eldrin F Lewis, et al.
European Journal of Heart Failure|February 28, 2014
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Carolyn S P Lam, Deepak K Gupta, et al.
Pageof 122